haloperidol has been researched along with Basal Ganglia Cerebrovascular Disease in 1 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Basal Ganglia Cerebrovascular Disease: A pathological condition caused by impaired blood flow in the basal regions of cerebral hemispheres (BASAL GANGLIA), such as INFARCTION; HEMORRHAGE; or ISCHEMIA in vessels of this brain region including the lateral lenticulostriate arteries. Primary clinical manifestations include involuntary movements (DYSKINESIAS) and muscle weakness (HEMIPARESIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Narumoto, J | 1 |
| Matsushima, N | 1 |
| Oka, S | 1 |
| Shimizu, H | 1 |
| Kooguchi, Y | 1 |
| Kitabayashi, Y | 1 |
| Kunizawa, M | 1 |
| Ueda, H | 1 |
| Fukui, K | 1 |
1 other study available for haloperidol and Basal Ganglia Cerebrovascular Disease
| Article | Year |
|---|---|
Neurobehavioral changes associated with bilateral caudate nucleus infarctions.
Topics: Basal Ganglia Cerebrovascular Disease; Caudate Nucleus; Cerebral Cortex; Cerebral Infarction; Delusi | 2005 |